Developed a Low-Cost Portable Nucleic Acid Amplification TB Detection device (cost $250)
Exploring CRISPR based gene editing technologies to identify markers of MDRTB
Integrated spectroscopy and optical detection methods to provide near real time detection of both TB and MDR-TB
Mumbai Municipal Cooperation, we are planning to create low-cost testing+ data repositories to map the endemic at local levels.
The Team has also validated data driven modelling techniques in epidemic control.
Our Unique Value Proposition
to reduce TB- ideal positioning for impact investment (proven earlier for COVID in various states in India)
Current time Problems in
Tuberculosis (TB) is one of the most infectious and prevalent diseases in the world, with increasing rate of multiple drug-resistant tuberculosis (MDR-TB) incidence in the global south
Requiring specialist equipment available only in big cities in developing countries.
GeneXpert device is current gold standard for TB diagnosis
equipment costs > $10,000 for a single machine
Design of an Efficient, Ease-of-use and Affordable Artificial Intelligence based Nucleic Acid Amplification Diagnosis Technology for Tuberculosis and Multi-drug Resistant Tuberculosis”, (April, 2021)Read More